Skip to content
Recall Observatory FDA recall evidence

Drug product

Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 007045 USA, NDC 0591-2132-01

D-0461-2022

January 18, 2022

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 89422
Status
Terminated
Classification
Class II
Quantity
6205 100-count bottles
Official record key
drug-enforcement:D-0461-2022

Official wording

Reason: Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient

Code information: Lot# 100025842, 100028023, Exp Date 08/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specification